Insmed Incorporated

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INSM and other ETFs, options, and stocks.

About INSM

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.

CEO

William H. Lewis

CEOWilliam H. Lewis

Employees

912

Employees912

Headquarters

Bridgewater, New Jersey

HeadquartersBridgewater, New Jersey

Founded

1988

Founded1988

Employees

912

Employees912

INSM Key Statistics

Market cap

13.21B

Market cap13.21B

Price-Earnings ratio

-13.29

Price-Earnings ratio-13.29

Dividend yield

—

Dividend yield—

Average volume

1.84M

Average volume1.84M

High today

$74.08

High today$74.08

Low today

$70.94

Low today$70.94

Open price

$73.12

Open price$73.12

Volume

1.37M

Volume1.37M

52 Week high

$80.53

52 Week high$80.53

52 Week low

$21.92

52 Week low$21.92

Analyst ratings

100%

of 18 ratings

Buy

100%

Hold

Sell

Insmed Incorporated

Why Robinhood?

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. Show more

INSM Key Statistics

Analyst ratings

100%

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.